synthetic oligonucleotides

The deal marks the latest in a series of acquisition LGC has made in recent years to expand its presence on the nucleic acid chemistry market.

GenScript believes that CustomArray's oligonucleotide synthesis and microarray manufacturing technology will enable it to better serve its customers.

The Silicon Valley startup has launched with a proprietary automation platform, and counts CRISPR researcher Jennifer Doudna among its new investors.

The acquisition of San Diego-based ValueGene expands IDT's presence in Southern California. 

IDT said that the acquisition is expected to expand the customer base for its custom synthetic nucleic acid business across Southeast Asia.